No attention is usually focused on the possible involvement of immune mechanisms, particularly of autoimmunity, on the development and progress of atherosclerosis. The pioneering work occurring almost 50 years ago was overlooked, and the idea of atherosclerosis as an autoimmune disease only started gaining traction about 10 years ago. Our review discusses the recent findings and offers insights into the possibility that alterations of the immune system play a significant role in the development of atherosclerosis.

Institute of Microbiology Laboratory of Immunotherapy Prague Czech

University of Louisville Department of Pathology Louisville KY USA

Zobrazit více v PubMed

Mayerl C, Lukasser M, Sedivy R, et al. Atherosclerosis research from past to present--on the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow. Virchows Arch 2006;449:96-103. 10.1007/s00428-006-0176-7 PubMed DOI

Methe H, Weis M. Atherogenesis and inflammation--was Virchow right? Nephrol Dial Transplant 2007;22:1823-7. 10.1093/ndt/gfm112 PubMed DOI

Shoenfeld Y, Harats D, Wick G. Atherosclerosis and autoimmunity. Amsterdam; New York: Elsevier, 2001.

Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001;21:1876-90. 10.1161/hq1201.100220 PubMed DOI

Full LE, Ruisanchez C, Monaco C. The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther 2009;11:217. 10.1186/ar2631 PubMed DOI PMC

Yin C, Mohanta SK, Srikakulapu P, et al. Artery tertiary lymphoid organs: powerhouses of atherosclerosis immunity. Front Immunol 2016;7:387. 10.3389/fimmu.2016.00387 PubMed DOI PMC

Srikakulapu P, Hu D, Yin C, et al. Artery tertiary lymphoid organs control multilayered territorialized atherosclerosis B-cell responses in aged ApoE-/- mice. Arterioscler Thromb Vasc Biol 2016;36:1174-85. 10.1161/ATVBAHA.115.306983 PubMed DOI PMC

Hu D, Mohanta SK, Yin C, et al. Artery Tertiary Lymphoid Organs Control Aorta Immunity and Protect against Atherosclerosis via Vascular Smooth Muscle Cell Lymphotoxin beta Receptors. Immunity 2015;42:1100-15. 10.1016/j.immuni.2015.05.015 PubMed DOI PMC

Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6. 10.1016/S0140-6736(88)90741-6 PubMed DOI

Mayr M, Kiechl S, Willeit J, et al. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 2000;102:833-9. 10.1161/01.CIR.102.8.833 PubMed DOI

Kleindienst R, Xu Q, Willeit J, et al. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am J Pathol 1993;142:1927-37. PubMed PMC

Xu Q, Kiechl S, Mayr M, et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation 1999;100:1169-74. 10.1161/01.CIR.100.11.1169 PubMed DOI

Hirschfield GM, Pepys MB. C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM 2003;96:793-807. 10.1093/qjmed/hcg134 PubMed DOI

Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009;27:229-65. 10.1146/annurev.immunol.021908.132715 PubMed DOI

Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010;464:1357-61. 10.1038/nature08938 PubMed DOI PMC

Miller YI, Viriyakosol S, Worrall DS, et al. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 2005;25:1213-9. 10.1161/01.ATV.0000159891.73193.31 PubMed DOI

Dai G, Kaazempur-Mofrad MR, Natarajan S, et al. Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature. Proc Natl Acad Sci U S A 2004;101:14871-6. 10.1073/pnas.0406073101 PubMed DOI PMC

Bengmark S. Advanced glycation and lipoxidation end products--amplifiers of inflammation: the role of food. JPEN J Parenter Enteral Nutr 2007;31:430-40. 10.1177/0148607107031005430 PubMed DOI

Šíma P, Turek B, Bencko V. Nutriční imunologie: modulace imunity složkami nutrice. Prakticky Lekar 2013;93:158-62.

Edfeldt K, Swedenborg J, Hansson GK, et al. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002;105:1158-61. PubMed

Andersson J, Libby P, Hansson GK. Adaptive immunity and atherosclerosis. Clin Immunol 2010;134:33-46. 10.1016/j.clim.2009.07.002 PubMed DOI

Libby P. The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med 2008;263:517-27. 10.1111/j.1365-2796.2008.01965.x PubMed DOI PMC

Waldo SW, Li Y, Buono C, et al. Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Am J Pathol 2008;172:1112-26. 10.2353/ajpath.2008.070513 PubMed DOI PMC

Martinez FO, Gordon S, Locati M, et al. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006;177:7303-11. 10.4049/jimmunol.177.10.7303 PubMed DOI

Gordon S. The macrophage: past, present and future. Eur J Immunol 2007;37 Suppl 1:S9-17. 10.1002/eji.200737638 PubMed DOI

Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8:958-69. 10.1038/nri2448 PubMed DOI PMC

Shalhoub J, Falck-Hansen MA, Davies AH, et al. Innate immunity and monocyte-macrophage activation in atherosclerosis. J Inflamm (Lond) 2011;8:9. 10.1186/1476-9255-8-9 PubMed DOI PMC

Ilhan F, Kalkanli ST. Atherosclerosis and the role of immune cells. World J Clin Cases 2015;3:345-52. 10.12998/wjcc.v3.i4.345 PubMed DOI PMC

Mohanta SK, Yin C, Peng L, et al. Artery tertiary lymphoid organs contribute to innate and adaptive immune responses in advanced mouse atherosclerosis. Circ Res 2014;114:1772-87. 10.1161/CIRCRESAHA.114.301137 PubMed DOI

Jonasson L, Holm J, Skalli O, et al. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest 1985;76:125-31. 10.1172/JCI111934 PubMed DOI PMC

Hansson GK. Atherosclerosis--an immune disease: The Anitschkov Lecture 2007. Atherosclerosis 2009;202:2-10. 10.1016/j.atherosclerosis.2008.08.039 PubMed DOI

Hansson GK, Jonasson L, Holm J, et al. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. Clin Exp Immunol 1986;64:261-8. PubMed PMC

Hansson GK, Jonasson L, Seifert PS, et al. Immune mechanisms in atherosclerosis. Arteriosclerosis 1989;9:567-78. 10.1161/01.ATV.9.5.567 PubMed DOI

Stemme S, Faber B, Holm J, et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A 1995;92:3893-7. 10.1073/pnas.92.9.3893 PubMed DOI PMC

Song L, Leung C, Schindler C. Lymphocytes are important in early atherosclerosis. J Clin Invest 2001;108:251-9. 10.1172/JCI200111380 PubMed DOI PMC

Bobryshev YV. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur Heart J 2005;26:1700-4. 10.1093/eurheartj/ehi282 PubMed DOI

Bobryshev YV, Lord RS. Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc Res 1998;37:799-810. 10.1016/S0008-6363(97)00229-0 PubMed DOI

Palinski W, Witztum JL. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis. J Intern Med 2000;247:371-80. 10.1046/j.1365-2796.2000.00656.x PubMed DOI

Palinski W, Tangirala RK, Miller E, et al. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol 1995;15:1569-76. 10.1161/01.ATV.15.10.1569 PubMed DOI

Salonen JT, Yla-Herttuala S, Yamamoto R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992;339:883-7. 10.1016/0140-6736(92)90926-T PubMed DOI

Vetvicka V, Vetvickova J. Glucan in clinical trials. Int Clin Pathol J 2017;5:00133 10.15406/icpjl.2017.05.00133 DOI

Immunity in cancer and atherosclerosis